MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-05-2026
Orthofix Medical Total Assets 2011-2026 | OFIX
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Orthofix Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 851 M | 893 M | 925 M | 459 M | 477 M | 526 M | 496 M | 467 M | 405 M | 372 M | 400 M | 393 M | 423 M | 504 M | 696 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 925 M | 372 M | 552 M |
Quarterly Total Assets Orthofix Medical
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 887 M | 851 M | 833 M | 837 M | 823 M | 893 M | 868 M | 882 M | 906 M | 925 M | 906 M | 901 M | 917 M | 459 M | 450 M | - | 462 M | 477 M | 500 M | 502 M | 514 M | 526 M | 526 M | 526 M | 526 M | 496 M | 496 M | 496 M | 496 M | 467 M | 467 M | 467 M | 467 M | 405 M | 405 M | 405 M | 405 M | 372 M | 372 M | 372 M | 372 M | 400 M | 400 M | 400 M | 400 M | 393 M | 393 M | 393 M | 393 M | 412 M | 412 M | 412 M | 412 M | 465 M | 473 M | 473 M | 473 M | 685 M | 704 M | 704 M | 696 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 925 M | 372 M | 556 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
720 M | - | - | $ 3.31 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 11.2 | 0.27 % | $ 317 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 8.24 | 0.24 % | $ 1.24 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
86.1 M | $ 4.25 | -1.62 % | $ 159 M |  France |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
304 M | $ 2.31 | 6.94 % | $ 50.9 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.47 | -0.57 % | $ 29.2 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 18.5 | 1.48 % | $ 434 M | USA |
 |
LivaNova PLC
LIVN
|
2.61 B | $ 73.71 | 1.08 % | $ 4.02 B |  Britain |
 |
LENSAR
LNSR
|
71.4 M | $ 5.88 | 1.38 % | $ 70.3 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 11.23 | 3.5 % | $ 402 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.0 | -4.76 % | $ 16.9 M | USA |
 |
MiMedx Group
MDXG
|
343 M | $ 3.79 | 4.12 % | $ 560 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
Pulmonx Corporation
LUNG
|
129 M | $ 1.54 | 14.93 % | $ 62.7 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 37.74 | -1.64 % | $ 319 M | USA |
 |
Myomo
MYO
|
38.6 M | $ 0.91 | 5.08 % | $ 38.1 M | USA |
 |
Butterfly Network
BFLY
|
297 M | $ 4.39 | 6.94 % | $ 1.08 B | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Profound Medical Corp.
PROF
|
77.5 M | $ 6.92 | 2.82 % | $ 209 M | Canada |
 |
Globus Medical
GMED
|
5.3 B | $ 84.03 | 5.13 % | $ 11.4 B | USA |
 |
Insulet Corporation
PODD
|
3.19 B | $ 156.59 | 1.28 % | $ 11 B | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 37.01 | 2.29 % | $ 1.15 B | USA |
 |
Sintx Technologies
SINT
|
9.51 M | $ 2.21 | 0.45 % | $ 6.13 M | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 44.14 | 3.75 % | $ 1.3 B | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 91.49 | 1.09 % | $ 3.18 B | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 82.97 | 0.99 % | $ 48.5 B | USA |
 |
TransMedics Group
TMDX
|
1.07 B | $ 68.0 | 2.83 % | $ 2.31 B | USA |